• RI - Unifesp
    • Documentos
    • Tutoriais
    • Perguntas frequentes
    • Atendimento
    • Equipe
    • português (Brasil)
    • English
    • español
  • Sobre
    • RI Unifesp
    • Documentos
    • Tutoriais
    • Perguntas frequentes
    • Atendimento
    • Equipe
  • English 
    • português (Brasil)
    • English
    • español
    • português (Brasil)
    • English
    • español
  • Login
View Item 
  •   DSpace Home
  • Instituto de Saúde e Sociedade (ISS)
  • ISS - Artigos
  • View Item
  •   DSpace Home
  • Instituto de Saúde e Sociedade (ISS)
  • ISS - Artigos
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Incorporation of bioactive glass in calcium phosphate cement: An evaluation

Thumbnail
Date
2013-03-01
Author
Renno, Ana Claudia Muniz [UNIFESP]
van de Watering, F. C. J.
Nejadnik, M. R.
Crovace, Murilo Camuri
Zanotto, Edgar Dutra
Wolke, J. G. C.
Jansen, J. A.
van den Beucken, Jeroen J. J. P.
Type
Artigo
ISSN
1742-7061
Is part of
Acta Biomaterialia
DOI
10.1016/j.actbio.2012.11.009
Metadata
Show full item record
Abstract
Bioactive glasses (BGs) are known for their unique ability to bond to living bone. Consequently, the incorporation of BGs into calcium phosphate cement (CPC) was hypothesized to be a feasible approach to improve the biological performance of CPC. Previously, it has been demonstrated that BGs can successfully be introduced into CPC, with or without poly(D,L-lactic-co-glycolic) acid (PLGA) microparticles. Although an in vitro physicochemical study on the introduction of BG into CPC was encouraging, the biocompatibility and in vivo bone response to these formulations are still unknown. Therefore, the present study aimed to evaluate the in vivo performance of BG supplemented CPC, either pure or supplemented with PLGA microparticles, via both ectopic and orthotopic implantation models in rats. Pre-set scaffolds in four different formulations (1: CPC; 2: CPC/BG; 3: CPC/PLGA; and 4: CPC/PLGA/BG) were implanted subcutaneously and into femoral condyle defects of rats for 2 and 6 weeks. Upon ectopic implantation, incorporation of BG into CPC improved the soft tissue response by improving capsule and interface quality. Additionally, the incorporation of BG into CPC and CPC/PLGA showed 1.8- and 4.7-fold higher degradation and 2.2- and 1.3-fold higher bone formation in a femoral condyle defect in rats compared to pure CPC and CPC/PLGA, respectively. Consequently, these results highlight the potential of BG to be used as an additive to CPC to improve the biological performance for bone regeneration applications. Nevertheless, further confirmation is necessary regarding long-term in vivo studies, which also have to be performed under compromised wound-healing conditions. (C) 2012 Acta Materialia Inc. Published by Elsevier B.V. All rights reserved.
Citation
Acta Biomaterialia. Oxford: Elsevier B.V., v. 9, n. 3, p. 5728-5739, 2013.
Keywords
Bone substitute
Calcium phosphate cement
Bioactive glass
In vivo
Sponsorship
Smart Mix Program of the Netherlands Ministry of Economic Affairs
Netherlands Ministry of Education, Culture and Science
URI
https://repositorio.unifesp.br/handle/11600/36030
Collections
  • ISS - Artigos [696]

DSpace software copyright © 2002-2016  DuraSpace
Contact Us
Theme by 
Atmire NV
 

 

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsBy Submit DateThis CollectionBy Issue DateAuthorsTitlesSubjectsBy Submit Date

My Account

Login

Statistics

View Usage Statistics

DSpace software copyright © 2002-2016  DuraSpace
Contact Us
Theme by 
Atmire NV